Partner Content Partner Content Hear from leading microbiologists at SMi’s Pharmaceutical Mi... Hear from the leading microbiologists at Pharma Micro
Events Partner Content SMi’s 3rd Annual Pharmaceutical Microbiology West Coast Conf... Pharmaceutical Microbiology West Coast 2019
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.